Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Vascular endothelial growth factor genetic variability and coronary artery disease in Brazilian population

Full text
Author(s):
Biselli, Patricia Matos [1] ; Guerzoni, Alexandre Rodrigues [1] ; de Godoy, Moacir Fernandes [2] ; Pavarino-Bertelli, Erika Cristina [1, 3] ; Goloni-Bertollo, Eny Maria [1, 3]
Total Authors: 5
Affiliation:
[1] Sao Jose Rio Preto Med Sch, Unidad Pesquisa Genet & Biol Mol UPGEM, Genet & Mol Biol Res Unit, BR-15090000 Famerp, SP - Brazil
[2] Sao Jose Rio Preto Med Sch, Dept Cardiol, BR-15090000 Famerp, SP - Brazil
[3] Sao Jose Rio Preto Med Sch, Dept Mol Biol, BR-15090000 Famerp, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: HEART AND VESSELS; v. 23, n. 6, p. 371-375, NOV 2008.
Web of Science Citations: 37
Abstract

Atherosclerosis results from a complex interaction between environment and genetic risk factors. The gene encoding vascular endothelial growth factor (VEGF) is associated with differential protein expression and has been investigated in coronary artery disease (CAD) studies. Based on this, we aimed at determining if patients with CAD are affected by polymorphisms (-2 578, -1 154, and 936) in the VEGF gene, and also if these polymorphisms are associated with the number of diseased vessels and degree of arterial obstruction. The case group was formed by 175 Caucasian patients with angiographically confirmed CAD, and the control group involved 108 Caucasian patients with normal coronary angiograms. Polymerase chain reaction (PCR) was used for genotyping. Allele frequencies for VEGF -2 578A, -1 154A, and 936T were 0.46, 0.38, and 0.14 in cases and 0.49, 0.30, and 0.13 in control subjects. Allele and genotype distribution did not significantly differ between groups. A higher frequency of the VEGF -2 578AA genotype was observed in the group with three vessel disease (P = 0.008). No association between the VEGF -2 578, -1 154, and 936 polymorphisms and degree of arterial obstruction was observed. The frequency of carriers of two copies of the haplotype AG (-2 578/-1 154) were higher in the group with three-vessel disease (P = 0.05). In summary, our report shows that the VEGF -2 578 polymorphism has an influence on CAD severity, possibly because of a reduced VEGF expression, suggesting a protective effect of VEGF in atherosclerosis. (AU)